{
 "PrintNo":"A5099","Session":2025,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2025-02-12T11:13:58.995816Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2025-02-12","Committee":"Health"}],
 "Actions":[{"Text":"REFERRED TO HEALTH","Date":"2025-02-12","Chamber":"ASSEMBLY"}],
 "Sponsors":[
  {"ID":1147,"Name":"Steve Stern","Short":"STERN"},{"ID":1535,"Name":"MaryJane Shimsky","Short":"SHIMSKY"},
  {"ID":1131,"Name":"Stacey Pheffer Amato","Short":"PHEFFER AMATO"},
  {"ID":1249,"Name":"Marianne Buttenschon","Short":"BUTTENSCHON"},{"ID":500,"Name":"William Colton","Short":"COLTON"},
  {"ID":1487,"Name":"William Conrad","Short":"CONRAD"},{"ID":1244,"Name":"Charles Fall","Short":"FALL"},
  {"ID":1120,"Name":"Billy Jones","Short":"JONES"},{"ID":1486,"Name":"Jen Lunsford","Short":"LUNSFORD"},
  {"ID":670,"Name":"Angelo Santabarbara","Short":"SANTABARBARA"},{"ID":571,"Name":"Albert A. Stirpe","Short":"STIRPE"},
  {"ID":907,"Name":"Jo Anne Simon","Short":"SIMON"},{"ID":1116,"Name":"Jaime R. Williams","Short":"WILLIAMS"},
  {"ID":608,"Name":"Edward Ra","Short":"RA"},{"ID":1461,"Name":"Keith Brown","Short":"BROWN K"},
  {"ID":1509,"Name":"Eric Brown","Short":"BROWN E"},{"ID":631,"Name":"Kenneth Blankenbush","Short":"BLANKENBUSH"},
  {"ID":1511,"Name":"Jake Ryan Blumencranz","Short":"BLUMENCRANZ"},
  {"ID":1238,"Name":"Joe DeStefano","Short":"DESTEFANO"},{"ID":1465,"Name":"Jerett Gandolfo","Short":"GANDOLFO"},
  {"ID":1466,"Name":"Michael Durso","Short":"DURSO"},{"ID":480,"Name":"David McDonough","Short":"MCDONOUGH"},
  {"ID":1544,"Name":"Scott Gray","Short":"GRAY"},{"ID":1536,"Name":"Matthew Slater","Short":"SLATER"},
  {"ID":1528,"Name":"Lester Chang","Short":"CHANG"},{"ID":1554,"Name":"Rebecca Kassay","Short":"KASSAY"}
 ],
 "Title":"Adds xylazine to the depressants designated as controlled substances",
 "Summary":"Adds xylazine to the depressants designated as controlled substances with the exception of use in cattle or other nonhuman species if approved by the federal food and drug administration.",
 "LawSection":"Public Health Law","LawCode":"Amd §§3305 & 3306, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to adding xylazine to the depressants designated as controlled substances",
 "SameAsPrintNo":"S4676-2025","PreviousVersions":["A8395-2023"]
}